Center Rob J, Wheatley Adam K, Campbell Shahan M, Gaeguta Adriana J, Peut Viv, Alcantara Sheilajen, Siebentritt Carly, Kent Stephen J, Purcell Damian F J
Department of Microbiology and Immunology, University of Melbourne, Parkville, 3010 VIC, Australia.
Vaccine. 2009 Nov 5;27(47):6605-12. doi: 10.1016/j.vaccine.2009.08.016. Epub 2009 Aug 25.
We developed highly expressing clade B and AE DNA and envelope protein (Env) vaccines for evaluation in mice and macaques as DNA prime/protein boost regimens. High levels of Env-specific antibodies were induced in mice, albeit with limited neutralizing activity in vitro. A combined clade B and AE regimen induced high titer Env-specific antibody in two pigtail macaques that neutralized several strains of HIV-1. However, upon mucosal challenge with SHIV(SF162P3) no protection from infection was observed. Although the vaccines tested provide a platform for inducing robust humoral immunity, further refinements to broaden coverage against divergent strains and induce mucosal immunity are needed.
我们开发了高表达的B亚型和AE亚型DNA及包膜蛋白(Env)疫苗,用于在小鼠和猕猴中作为DNA初免/蛋白加强方案进行评估。在小鼠中诱导出了高水平的Env特异性抗体,尽管体外中和活性有限。B亚型和AE亚型联合方案在两只食蟹猕猴中诱导出了高滴度的Env特异性抗体,该抗体可中和多种HIV-1毒株。然而,在用SHIV(SF162P3)进行黏膜攻击后,未观察到对感染的保护作用。尽管所测试的疫苗提供了一个诱导强大体液免疫的平台,但仍需要进一步改进以扩大对不同毒株的覆盖范围并诱导黏膜免疫。